Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05903950
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05903950
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Qatar
- Registry status
- Recruiting
Technical summary
Registry record NCT05903950. Randomized; triple masking; primary purpose prevention. Start 2024-11-03 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
- Acronym
- APCIQ-BP
- Condition
- Hypertension, Systolic
- Condition
- Metabolic Syndrome
- Condition
- Typ 2 Diabetes
- Intervention (Device)
- Air cleaners with HEPA filter
- Intervention (Device)
- Air cleaners without HEPA filter
- Lead sponsor
- Weill Cornell Medical College in Qatar
- Collaborator
- Hamad Medical Corporation
Record details
- Record id
cardio:ct-nct05903950- Content hash
a49591221dccabc899c1fda325222a3d992f1cef4d4e32d0dd706bb90f3a9f83